Editorial
doi: 10.1155/2012/267251.
The role of CFTR mutations in asthma
- PMID: 22332134
- PMCID: PMC3299039
- DOI: 10.1155/2012/267251
Item in Clipboard
Editorial
The role of CFTR mutations in asthma
Can Respir J.
2012 Jan-Feb.
No abstract available
Comment on
-
Cystic fibrosis transmembrane conductance regulator gene abnormalities in patients with asthma and recurrent neutrophilic bronchitis.Can Respir J. 2012 Jan-Feb;19(1):46-8. doi: 10.1155/2012/546702. Can Respir J. 2012. PMID: 22332135 Free PMC article.
Similar articles
-
Cystic fibrosis transmembrane conductance regulator gene abnormalities in patients with asthma and recurrent neutrophilic bronchitis.Can Respir J. 2012 Jan-Feb;19(1):46-8. doi: 10.1155/2012/546702. Can Respir J. 2012. PMID: 22332135 Free PMC article.
-
Detection of CFTR gene mutations in patients suffering from chronic bronchitis.Arch Med Res. 2000 Jan-Feb;31(1):97-100. doi: 10.1016/s0188-4409(99)00065-x. Arch Med Res. 2000. PMID: 10767489
-
Missense mutations in the cystic fibrosis gene in adult patients with asthma.Hum Mutat. 1999;14(6):510-9. doi: 10.1002/(SICI)1098-1004(199912)14:6<510::AID-HUMU10>3.0.CO;2-O. Hum Mutat. 1999. PMID: 10571949
-
Association of CFTR gene mutation with bronchial asthma.Indian J Med Res. 2012 Apr;135(4):469-78. Indian J Med Res. 2012. PMID: 22664493 Free PMC article. Review.
-
'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations.Respir Res. 2001;2(6):328-32. doi: 10.1186/rr82. Epub 2001 Aug 9. Respir Res. 2001. PMID: 11737931 Free PMC article. Review.
Cited by
-
Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus Clearance.Clin Chest Med. 2016 Mar;37(1):147-58. doi: 10.1016/j.ccm.2015.11.003. Epub 2015 Dec 24. Clin Chest Med. 2016. PMID: 26857776 Free PMC article. Review.
-
Epithelial Sodium and Chloride Channels and Asthma.Chin Med J (Engl). 2015 Aug 20;128(16):2242-9. doi: 10.4103/0366-6999.162494. Chin Med J (Engl). 2015. PMID: 26265620 Free PMC article. Review.
-
The therapeutic potential of CFTR modulators for COPD and other airway diseases.Curr Opin Pharmacol. 2017 Jun;34:132-139. doi: 10.1016/j.coph.2017.09.013. Epub 2017 Nov 10. Curr Opin Pharmacol. 2017. PMID: 29132121 Free PMC article. Review.
-
Modulator-refractory cystic fibrosis: Defining the scope and challenges of an emerging at-risk population.Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241297877. doi: 10.1177/17534666241297877. Ther Adv Respir Dis. 2024. PMID: 39543951 Free PMC article. Review.
-
Role of CFTR in epithelial physiology.Cell Mol Life Sci. 2017 Jan;74(1):93-115. doi: 10.1007/s00018-016-2391-y. Epub 2016 Oct 6. Cell Mol Life Sci. 2017. PMID: 27714410 Free PMC article. Review.
References
-
- Warner JO, Norman AP, Soothill JF. Cystic fibrosis heterozygosity in the pathogenesis of allergy. Lancet. 1976;1:990–1. - PubMed
-
- Gyurkovits K, Markus V, Bittera I. Cystic-fibrosis heterozygosity in childhood bronchial asthma. Lancet. 1977;1:203. - PubMed
-
- Davis PB. Autonomic and airway reactivity in obligate heterozygotes for cystic fibrosis. Am Rev Respir Dis. 1984;129:911–4. - PubMed
-
- Schroeder SA, Gaughan DM, Swift M. Protection against bronchial asthma by CFTR ΔF508 mutation: A heterozygote advantage in cystic fibrosis. Nat Med. 1995;1:703–5. - PubMed
-
- Mennie M, Gilfillan A, Brock DJ, Liston WA. Heterozygotes for the ΔF508 cystic fibrosis allele are not protected against bronchial asthma. Nat Med. 1995;1:978–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
